Vutrisiran (Amvuttra®) – Treats polyneuropathy

In an 18-month clinical study, AMVUTTRA-treated patients showed significant improvement in nerve function and quality of life at 9 months and continued to improve throughout the study, compared with those who received placebo in a similar study. [source: NIH]